Prebiotic oligosaccharides improve gut and metabolic health

Prebiotic oligosaccharides, such as inulin or fructo-oligosaccharides, durably transform digestive and overall health. These compounds, naturally present in foods like garlic, onions, bananas, or chicory, selectively stimulate the growth of beneficial bacteria in the gut, particularly bifidobacteria and lactobacilli. Their fermentation by the microbiota produces short-chain fatty acids, such as acetate, propionate, and butyrate, which are essential for strengthening the intestinal barrier, reducing inflammation, and regulating the immune system.

These fatty acids play a key role in protecting the intestinal mucosa by maintaining a balanced pH and limiting the proliferation of harmful microbes. They also influence energy metabolism and communication between the gut and other organs, such as the brain or liver. For example, increased propionate production in the colon can reduce fat accumulation in the liver, while butyrate nourishes colon cells and modulates the expression of immunity-related genes.

Oligosaccharides do more than just affect digestion. They improve the texture, sweetness, and stability of functional foods while preserving their biological properties. Modern techniques, such as encapsulation, protect these compounds from degradation during digestion, ensuring targeted release in the colon. When combined with probiotics in synbiotic formulations, they enhance their effects by promoting the durable colonization of beneficial bacteria.

Their therapeutic impact extends to managing various disorders. They relieve symptoms of irritable bowel syndrome, constipation, or chronic inflammatory bowel diseases by restoring gut microbiota balance and reducing inflammation. In the metabolic field, certain oligosaccharides help combat obesity and diabetes by improving insulin sensitivity, regulating blood sugar levels, and modulating lipid storage. Their action on the gut-brain axis also opens perspectives for treating neurodegenerative disorders or psychological conditions, such as depression or anxiety, by influencing the production of neurotransmitters like serotonin.

However, their use is not without challenges. Excessive consumption can cause bloating or gas, especially in sensitive individuals or those with digestive disorders. The individual variability of the microbiota also affects their effectiveness, making a personalized approach necessary. Production costs, technological challenges for large-scale manufacturing, and strict regulations on health claims still limit their widespread adoption.

Recent innovations, such as the use of artificial intelligence to predict individual responses or the development of next-generation prebiotics, promise to optimize their use. These advances could enable precise targeting of each person’s needs based on their microbiota and expand their applications in functional foods and therapies. Prebiotic oligosaccharides thus establish themselves as major allies for preventive and personalized health.

Content References

Official Reference

DOI: https://doi.org/10.1007/s13205-026-04776-1

Title: Oligosaccharide prebiotics in functional foods and therapeutics: innovations and challenges

Journal: 3 Biotech

Publisher: Springer Science and Business Media LLC

Authors: K. S. Sandra; Megh Pravin Vithalkar; Vishnusai Beere; H. B. Bharath; B. Satyanarayana; Mohamed Rafiq; Yogendra Nayak